Could there be today something better than Byetta? The marketing folks at Novo Nordisk absolutely desire us to think so. In January 2010 regulators gave their endorsement to sell the new drug for type 2 diabetes named Victoza in the world’s biggest market for diabetes medications, the USA.
Victoza is a new drug in the class of medications referred to as GLP 1 analogues. Glucagon-like peptide one, or GLP 1 for brief, is a hormone released by the lining of the intestines of yours when there is food in the gut of yours. GLP-1 has a selection of functions that help lower blood sugars. Victoza:
So what’s to not love about any drug that mimics GLP-1?
The problem is sometimes the total effect of the drug is to lower blood sugars, and at times prescriptions in this category, which also contains Byetta, increase blood sugars. And both glucotrust side effects (darkphoenixstudio.com) may be radical.
The regular benefit of taking either Byetta or Victoza is a lowering of the HbA1c level of yours of about 1 %. That’s incredibly helpful, though you get very much benefit from the far less costly metformin or the absolutely cost-free changes you are able to make in your blood sugar levels with a sensible plant based diet.